SynopsisThe US market for emergency room equipment includes: Patient monitoring, Imaging, Hitech, Cardiac, Vascular and Trauma equipment. The global Emergency Room Equipment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030.....
SynopsisThere is an increasing adoption of gelatin and bone glue in orthopedic surgeries in Europe and this is expected to boost the demand for gelatin and bone glue in the region over the forecast period. The global Gelatin and Bone Glue market was valued at US.....
Synopsis Global cardiopulmonary stress testing systems market is mainly driven by the rising demand for high value low volume products, and increasing innovations in the new product launches. The market is witnessing growing trend of introduction of wi.....
SynopsisMetabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc. The global Drugs for Metabolic Disorders marke.....
SynopsisBlood pressure transducers are the machine used to measure venous and arterial blood pressure. Blood pressure transducer is a lightweight and small machine containing a lean flexible metallic diaphragm linked to straining device through inductive connection. T.....
SynopsisTysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried .....
Synopsis Nuclear medicine utilizes radionuclides, which are unstable atoms that emit radiation spontaneously, to examine and treat diseases such as, cancer, cardiovascular, and others. The global Nuclear Medicine Equipment market was valued at .....
SynopsisInfliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. The global Remicade (infliximab) Drug market was valued at US$.....
SynopsisLive, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. The global Cholera Vaccines Oral Live market was valued at US$ 85 million in 2023 and is anticipated to reach US$ 143.7 millio.....
SynopsisThe global Lixisenatide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Lixisenatide is estimated to increase from $ million .....
